학술논문
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
Document Type
Article
Author
Nooka, A.K.; Lonial, S.; Cohen, A.D.; Lee, H.C.; Badros, A.; Suvannasankha, A.; Callander, N.; Abdallah, A.-O.; Trudel, S.; Chari, A.; Libby, E.N.; Chaudhry, M.; Hultcrantz, M.; Kortüm, K.M.; Popat, R.; Sborov, D.; Hakim, S.; Gorsh, B.; Opalinska, J.; Lewis, E.; Gupta, I.; Bhushan, B.; McKeown, A.; Richardson, P.G.
Source
In: Cancer . (Cancer, 1 December 2023, 129(23):3746-3760)
Subject
Language
English
ISSN
10970142
0008543X
0008543X